GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

Resbiotic Nutrition Inc. ("resbiotic" or "res"), a leading provider of physician-formulated and science-backed dietary supplements, has announced a strategic distribution agreement with Grupo Columbia ...

The Chalk River Nuclear Facility is cited as the largest supplier of medical radioisotopes in the world. (Chalk River was ...

BOCA RATON, FL, UNITED STATES, January 27, 2025 /EINPresswire / -- With rising business confidence indicators from Moody's and The Nationa ...

WASHINGTON — Mexico denied a U.S. military plane access to land Thursday, at least temporarily frustrating the Trump administration's plans to deport immigrants to the country, according to two ...

The Oral Care Market growth is driven by increasing awareness, smart oral hygiene products, and eco-friendly innovations.Pune, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Oral Care Market Size & Growth Analysis ...

"It's unprecedented," Licon said Tuesday of Mexico's plan to build shelter and reception centers in nine cities south of the U.S.-Mexico border. Authorities at the site will reportedly provide ...

GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

Investing.com-- Most Asian currencies edged higher on Wednesday as investors were cautious amid the ongoing Federal Reserve ...

U.S. stock futures and the dollar were both sliding on Friday as Asian markets rallied after President Trump signaled he ...